In our previous study directly focusing on the expression of putative stem cell markers in EMT-derived tumour cells, we describe a low frequency of CD44s, CD166, and EpCAM staining within tumour buds, thus emphasising the loss of cell adhesion molecules typical of these cells (Hostettler et al, 2010). The gene discussed is ALCAM; the disease is neoplasm.